Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03482362Phase 2Completed
Vinorelbine in Advanced BRAF-like Colon Cancer
Colon Cancer
PrincipalinvestigatorStart date: 2018-03-01
NCT03470350Phase 1/2Withdrawn
Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer
Colorectal Cancer Metastatic
Principalinvestigator

Research Network

Collaboration Network

12 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Agendia

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sabine Hazan, MD

ProgenaBiome

Moderately Similar
41 trials

Shared therapeutic areas:

Cancer of ColonColorectal Cancer Metastatic
Similarity Score30%

Yanhong Deng, M.D.

Sixth Affiliated Hospital, Sun Yat-sen University

Moderately Similar
8 trials

Shared therapeutic areas:

Cancer of ColonColorectal Cancer Metastatic
Similarity Score30%

Lillian Siu, MD

Princess Margaret Cancer Centre

Moderately Similar
12 trials

Shared therapeutic areas:

Cancer of ColonColorectal Cancer Metastatic
Similarity Score30%

Norman Wolmark, MD

NSABP Foundation Inc

Moderately Similar
54 trials

Shared therapeutic areas:

Cancer of ColonColorectal Cancer Metastatic

Worked with same sponsors:

Eli Lilly and Company
Similarity Score30%

S Siena, Prof

ONCG

Related
3 trials

Shared therapeutic areas:

Colorectal Cancer MetastaticCancer of Colon

Worked with same sponsors:

AgendiaAzienda Ospedaliera Niguarda Cà Granda+9 more
Collaborated on 2 trials
Similarity Score28%

A Bardelli, Prof

UNITO

Related
3 trials

Shared therapeutic areas:

Colorectal Cancer MetastaticCancer of Colon

Worked with same sponsors:

AgendiaAzienda Ospedaliera Niguarda Cà Granda+9 more
Collaborated on 2 trials
Similarity Score28%

R Salazar, MD, PhD

ICO

Related
3 trials

Shared therapeutic areas:

Colorectal Cancer MetastaticCancer of Colon

Worked with same sponsors:

AgendiaAzienda Ospedaliera Niguarda Cà Granda+9 more
Collaborated on 2 trials
Similarity Score28%

S Tejpar, Prof

UZ Leuven

Related
3 trials

Shared therapeutic areas:

Colorectal Cancer MetastaticCancer of Colon

Worked with same sponsors:

AgendiaAzienda Ospedaliera Niguarda Cà Granda+9 more
Collaborated on 2 trials
Similarity Score28%

J Tabernero, Prof

VHIO

Related
3 trials

Shared therapeutic areas:

Colorectal Cancer MetastaticCancer of Colon

Worked with same sponsors:

AgendiaAzienda Ospedaliera Niguarda Cà Granda+9 more
Collaborated on 2 trials
Similarity Score28%

A Cervantes, Prof

Instituto de Investigacion Sanitaria INCLIVA

Related
3 trials

Shared therapeutic areas:

Colorectal Cancer MetastaticCancer of Colon

Worked with same sponsors:

AgendiaAzienda Ospedaliera Niguarda Cà Granda+9 more
Collaborated on 2 trials
Similarity Score28%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03482362Phase 2PrincipalInvestigator

Vinorelbine in Advanced BRAF-like Colon Cancer

Colon Cancer
Completed
NCT03470350Phase 1/2PrincipalInvestigator

Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer

Colorectal Cancer Metastatic
Withdrawn

All 2 trials loaded